Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zimmer's smaller units shine in "acceptable" Q2

This article was originally published in Clinica

Executive Summary

Zimmer's 15% second-quarter sales increase, to $847m, was driven by solid growth in its biggest segments, while its smaller business activities, dental and spine, turned in particularly robust performances. Group net income rose by 64% to $191m. Spinal sales were up by 22% to $41m, while dental revenues rose by 28% to $40m. As Merrill Lynch analyst Michael Jungling noted, Zimmer Dental is the fourth-largest dental implant business with a worldwide market share of around 10%. He said it was one of the faster growing businesses. Meanwhile, Zimmer's main businesses of hip and knee products grew by 20% (to $354m) and 10% (to $294m), respectively, driven by its focus on minimally-invasive techniques.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055964

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel